Dalfampridine in patients with downbeat nystagmus - An observational study

Journal of Neurology

Volumn 260, Issue 8, 2013, Pages 1992-1996

  Claassen, Jens ^a   Feil, Katharina ^a   Bardins, Stanislav ^a   Teufel, Julian ^a   Spiegel, Rainer ^a   Kalla, Roger ^a   Schneider, Erich ^a   Jahn, Klaus ^a   Schniepp, Roman ^a   Strupp, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Clinical Neurology; Dalfampridine; Downbeat nystagmus; Neuro Ophthalmology; Neurotology

Indexed keywords

4 AMINOPYRIDINE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIZZINESS; DRUG EFFECT; EYE MOVEMENT; FEMALE; HUMAN; MALAISE; MALE; NYSTAGMUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TREATMENT DURATION; VISUAL ACUITY;

EID: 84881554073     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6911-5     Document Type: Article

References (14)

1. Baloh RW, Spooner JW (1981) Downbeat nystagmus: a type of central vestibular nystagmus. Neurology 31:304-310
2. Hufner K, Stephan T, Kalla R et al (2007) Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus. Neurology 69:1128-1135
3. Kalla R, Deutschlander A, Hufner K et al (2006) Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 66:281-283
4. Zee DS, Yamazaki A, Butler PH, Gucer G (1981) Effects of ablation of flocculus and paraflocculus of eye movements in primate. J Neurophysiol 46:878-899
5. Marti S, Straumann D, Buttner U, Glasauer S (2008) A model-based theory on the origin of downbeat nystagmus. Exp Brain Res Experimentelle Hirnforschung Experimentation cerebrale 188:613-631
6. Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M (2007) 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain:J Neurol 130:2441-2451
7. Kalla R, Glasauer S, Schautzer F et al (2004) 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology 62:1228-1229
8. Kalla R, Spiegel R, Claassen J et al (2011) Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuro-ophthalmol:Off J North Am Neuro-Ophthalmol Soc 31:320-325
9. Strupp M, Schuler O, Krafczyk S et al (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165-170
10. Etzion Y, Grossman Y (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res Experimentelle Hirnforschung Experimentation cerebrale 139:419-425
11. Alvina K, Khodakhah K (2010) The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci:Official J Soc Neurosci 30:7258-7268
12. Hayes KC, Katz MA, Devane JG et al (2003) Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury. J Clin Pharmacol 43:379-385
13. Hayes KC, Potter PJ, Hsieh JT, Katz MA, Blight AR, Cohen R (2004) Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Arch Phys Med Rehabil 85:29-34
14. Spiegel R, Rettinger N, Kalla R et al (2009) The intensity of downbeat nystagmus during daytime. Ann N Y Acad Sci 1164:293-299